XML 38 R27.htm IDEA: XBRL DOCUMENT v3.24.3
Derivative Financial Instruments (Tables)
3 Months Ended
Sep. 28, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Fair Value of Derivative Instruments in Consolidated Balance Sheets
The following table summarizes the fair value of the derivative instruments in the Consolidated Balance Sheets as of September 28, 2024 and September 30, 2023 (in thousands):
Fair Value
Derivatives designated as hedging instruments under Subtopic 815-20Balance Sheet LocationSeptember 28, 2024June 29, 2024
Foreign currency forward contractsOther current liabilities$1,360 $277 
Schedule of Gain (Loss) of Derivative Instruments in Statement of Operations
The following tables summarize the gain (loss) on derivative instruments, net of tax, on the Consolidated Statements of Operations for the three months ended September 28, 2024 and September 30, 2023, respectively (in thousands):
Derivatives Designated as Hedging InstrumentsClassification of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)AOCI Balance
as of
June 30, 2024
Effective
Portion
Recorded In
AOCI
Effective Portion
Reclassified From
AOCI Into
Income
AOCI Balance
as of
September 28, 2024
Forward contractsCost of sales$215 $540 $298 $1,053 
Total$215 $540 $298 $1,053 
Derivatives Designated as Hedging InstrumentsClassification of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)AOCI Balance
as of
July 1, 2023
Effective
Portion
Recorded In
AOCI
Effective Portion
Reclassified From
AOCI Into
Income
AOCI Balance
as of
September 30, 2023
Interest rate swapInterest expense(97)— 58 (39)
Total$(97)$— $58 $(39)